Nationwide Fund Advisors’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-24,188
| Closed | -$2.23M | – | 2857 |
|
|
2017
Q3 | $2.23M | Sell |
24,188
-13,661
| -36% | -$1.26M | 0.01% | 1400 |
|
|
2017
Q2 | $3.04M | Buy |
37,849
+10,415
| +38% | +$835K | 0.01% | 1255 |
|
|
2017
Q1 | $1.15M | Buy |
27,434
+6,632
| +32% | +$279K | ﹤0.01% | 1667 |
|
|
2016
Q4 | $668K | Sell |
20,802
-1,090
| -5% | -$35K | ﹤0.01% | 2003 |
|
|
2016
Q3 | $573K | Sell |
21,892
-1,500
| -6% | -$39.3K | ﹤0.01% | 2113 |
|
|
2016
Q2 | $542K | Buy |
23,392
+17,775
| +316% | +$412K | ﹤0.01% | 2110 |
|
|
2016
Q1 | $154K | Sell |
5,617
-27
| -0.5% | -$740 | ﹤0.01% | 2647 |
|
|
2015
Q4 | $161K | Sell |
5,644
-9,314
| -62% | -$266K | ﹤0.01% | 2648 |
|
|
2015
Q3 | $261K | Hold |
14,958
| – | – | ﹤0.01% | 2435 |
|
|
2015
Q2 | $270K | Buy |
14,958
+2,405
| +19% | +$43.4K | ﹤0.01% | 2554 |
|
|
2015
Q1 | $156K | Hold |
12,553
| – | – | ﹤0.01% | 2815 |
|
|
2014
Q4 | $147K | Buy |
12,553
+5,428
| +76% | +$63.6K | ﹤0.01% | 2787 |
|
|
2014
Q3 | $94K | Buy |
+7,125
| New | +$94K | ﹤0.01% | 3008 |
|